Forte Biosciences CEO & CFO Buy Shares Amid 38% Weekly Rise – Signals Confidence in Oncology & Value‑Based Care
Forte Biosciences insider buying shows executive confidence amid a 38 % weekly stock surge, AI‑driven oncology R&D, and value‑based payer strategies.
4 minutes to read